title: Reduced levels of IE2 gene expression and shutdown of early and late viral genes during latent infection of the glioblastoma cell line U138-MG with selectable recombinants of human cytomegalovirus.
abstract: To establish stable culture conditions which support persistence of the human cytomegalovirus (HCMV) genome in a latent state, the expression of the bacterial neomycin phosphotransferase (neo) from HCMV recombinants was used for selection. Different cell lines were infected with HCMV recombinants. The human glioblastoma line U138-MG was rendered resistant to G418 and retained the viral genome. More than 90% of the cells expressed the viral IE1 protein of 72 kDa for a culture period of 18 months. Many fewer cells expressed IE2-encoded proteins. No late gene expression or infectious virus was detectable. IE2 gene expression in latently infected cells appeared to be restricted at the level of RNA accumulation. Treatment with TPA or retinoic acid led to enhanced expression of the IE2 gene and the early genes encoding pp65 (UL83) and p52 (UL44). Superinfection with wild-type HCMV led to replication of neo-recombinant virus, indicating that replication-competent virus had been retained in latently infected U138-MG and that the cells had kept their permissive phenotype. Latent HCMV infection in U138-MG cells provides a useful model system for studying the role of particular viral and cellular genes in latent and permissive infections.
authors.affiliation: Institut für Klinische und Molekulare Virologie, Universität Erlangen-Nürnberg, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Wolff
authors.forename: C
authors.initials: C
authors.lastname: Sinzger
authors.forename: P
authors.initials: P
authors.lastname: Drescher
authors.forename: G
authors.initials: G
authors.lastname: Jahn
authors.forename: B
authors.initials: B
authors.lastname: Plachter
mesh_terms: D003587:Cytomegalovirus / Q000235:genetics* / Q000502:physiology; D004279:DNA, Viral / Q000032:analysis; D015967:Gene Expression Regulation, Viral / Q000235:genetics*; D017781:Genes, Immediate-Early / Q000235:genetics; D016679:Genome, Viral; D005909:Glioblastoma / Q000382:microbiology*; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics*; D019868:Kanamycin Kinase; D008562:Membrane Glycoproteins; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D012367:RNA, Viral / Q000032:analysis; D015534:Trans-Activators; D014407:Tumor Cells, Cultured; D014759:Viral Envelope Proteins; D014764:Viral Proteins / Q000032:analysis; D014775:Virus Activation; D017735:Virus Latency / Q000235:genetics*; D014779:Virus Replication
chemical_list: D004279:DNA, Viral; C088645:IE1 protein, cytomegalovirus; C069186:IE2 protein, Cytomegalovirus; D017874:Immediate-Early Proteins; D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D012367:RNA, Viral; D015534:Trans-Activators; C077406:UL115 protein, Human herpesvirus 5; D014759:Viral Envelope Proteins; D014764:Viral Proteins; C071440:glycoprotein H, Cytomegalovirus; C499358:glycoprotein H, Human cytomegalovirus; C439068:glycoprotein O, cytomegalovirus; D017853:Phosphotransferases (Alcohol Group Acceptor); D019868:Kanamycin Kinase